APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-invasive Prenatal Paternity Testing(NIPPT)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Analysis and Forecast 2026-2032

25 December 2025194 pages

Choose your research edition.

Industry ResearchNon-invasive Prenatal Paternity Testing(NIPPT) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-invasive Prenatal Paternity Testing(NIPPT) Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Non-invasive Prenatal Paternity Testing(NIPPT) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-invasive Prenatal Paternity Testing(NIPPT) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non-invasive Prenatal Paternity Testing(NIPPT) include BGI Genomics, Ultrasound Plus, Roche company, PrenatalGeneticslab, Natera, LabCorp, International Biosciences, Illumina and Express Diagnostic Center (EDC), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-invasive Prenatal Paternity Testing(NIPPT), market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-invasive Prenatal Paternity Testing(NIPPT), also provides the revenue of main regions and countries. Of the upcoming market potential for Non-invasive Prenatal Paternity Testing(NIPPT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-invasive Prenatal Paternity Testing(NIPPT) revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-invasive Prenatal Paternity Testing(NIPPT) revenue, projected growth trends, production technology, application and end-user industry.

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Company

BGI Genomics

Ultrasound Plus

Roche company

PrenatalGeneticslab

Natera

LabCorp

International Biosciences

Illumina

Express Diagnostic Center (EDC)

EasyDNA

DDC

Axis DNA Labs

AlphaBiolabs

AffinityDNA

Acecgt Group

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Type

Reagents

Service

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Application

Non-legal Paternity Test

Legal Paternity Test

Non-invasive Prenatal Paternity Testing(NIPPT) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-invasive Prenatal Paternity Testing(NIPPT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-invasive Prenatal Paternity Testing(NIPPT) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-invasive Prenatal Paternity Testing(NIPPT).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non-invasive Prenatal Paternity Testing(NIPPT) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non-invasive Prenatal Paternity Testing(NIPPT) company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-invasive Prenatal Paternity Testing(NIPPT) revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Reagents Major Player Table 3. Service Major Player Table 4. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Non-legal Paternity Test Major Player Table 6. Legal Paternity Test Major Player Table 7. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends Table 8. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Drivers Table 9. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Opportunities and Challenges Table 10. Non-invasive Prenatal Paternity Testing(NIPPT) Industry Restraints Table 11. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Share by Region (2021-2026) Table 14. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Share by Region (2027-2032) Table 16. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Players (2021-2026) Table 18. Global Non-invasive Prenatal Paternity Testing(NIPPT) Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Non-invasive Prenatal Paternity Testing(NIPPT) Key Players Headquarters & Area Served Table 20. Global Non-invasive Prenatal Paternity Testing(NIPPT) Players, Product Type & Application Table 21. Global Non-invasive Prenatal Paternity Testing(NIPPT) Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Non-invasive Prenatal Paternity Testing(NIPPT) by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Type (2021-2026) Table 28. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Type (2027-2032) Table 29. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2021-2026) Table 33. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2027-2032) Table 34. BGI Genomics Company Information Table 35. BGI Genomics Business Overview Table 36. BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 38. BGI Genomics Recent Development Table 39. Ultrasound Plus Company Information Table 40. Ultrasound Plus Business Overview Table 41. Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 43. Ultrasound Plus Recent Development Table 44. Roche company Company Information Table 45. Roche company Business Overview Table 46. Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 48. Roche company Recent Development Table 49. PrenatalGeneticslab Company Information Table 50. PrenatalGeneticslab Business Overview Table 51. PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 53. PrenatalGeneticslab Recent Development Table 54. Natera Company Information Table 55. Natera Business Overview Table 56. Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 58. Natera Recent Development Table 59. LabCorp Company Information Table 60. LabCorp Business Overview Table 61. LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 63. LabCorp Recent Development Table 64. International Biosciences Company Information Table 65. International Biosciences Business Overview Table 66. International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 68. International Biosciences Recent Development Table 69. Illumina Company Information Table 70. Illumina Business Overview Table 71. Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 73. Illumina Recent Development Table 74. Express Diagnostic Center (EDC) Company Information Table 75. Express Diagnostic Center (EDC) Business Overview Table 76. Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 78. Express Diagnostic Center (EDC) Recent Development Table 79. EasyDNA Company Information Table 80. EasyDNA Business Overview Table 81. EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 83. EasyDNA Recent Development Table 84. DDC Company Information Table 85. DDC Business Overview Table 86. DDC Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 88. DDC Recent Development Table 89. Axis DNA Labs Company Information Table 90. Axis DNA Labs Business Overview Table 91. Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 93. Axis DNA Labs Recent Development Table 94. AlphaBiolabs Company Information Table 95. AlphaBiolabs Business Overview Table 96. AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 98. AlphaBiolabs Recent Development Table 99. AffinityDNA Company Information Table 100. AffinityDNA Business Overview Table 101. AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 103. AffinityDNA Recent Development Table 104. Acecgt Group Company Information Table 105. Acecgt Group Business Overview Table 106. Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio Table 108. Acecgt Group Recent Development Table 109. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (US$ Million) & (2027-2032) Table 123. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 124. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 125. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 126. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Non-invasive Prenatal Paternity Testing(NIPPT) Image Figure 2. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Reagents Image Figure 5. Service Image Figure 6. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size Share 2021 VS 2025 VS 2032 Figure 8. Non-legal Paternity Test Image Figure 9. Legal Paternity Test Image Figure 10. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size (US$ Million) & (2021-2032) Figure 11. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Non-invasive Prenatal Paternity Testing(NIPPT) Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Type (2021-2032) Figure 18. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2021-2032) Figure 21. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032) Figure 23. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032) Figure 24. North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Country (2021-2032) Figure 25. United States Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032) Figure 30. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032) Figure 31. Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Country (2021-2032) Figure 32. Germany Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032) Figure 42. China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032) Figure 43. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032) Figure 45. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032) Figure 46. Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Region (2021-2032) Figure 47. Japan Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032) Figure 55. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032) Figure 56. SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Country (2021-2032) Figure 57. Brazil Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Non-invasive Prenatal Paternity Testing(NIPPT) Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Reagents
  • Service
Applications
  • Non-legal Paternity Test
  • Legal Paternity Test
Companies covered
  • BGI Genomics
  • Ultrasound Plus
  • Roche company
  • PrenatalGeneticslab
  • Natera
  • LabCorp
  • International Biosciences
  • Illumina
  • Express Diagnostic Center (EDC)
  • EasyDNA
  • DDC
  • Axis DNA Labs
  • AlphaBiolabs
  • AffinityDNA
  • Acecgt Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Type
  3. 1.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Reagents
  5. 1.2.3 Service
  6. 1.3 Non-invasive Prenatal Paternity Testing(NIPPT) Market by Application
  7. 1.3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Non-legal Paternity Test
  9. 1.3.3 Legal Paternity Test
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Non-invasive Prenatal Paternity Testing(NIPPT) Market Dynamics
  1. 2.1 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Trends
  2. 2.2 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Drivers
  3. 2.3 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Opportunities and Challenges
  4. 2.4 Non-invasive Prenatal Paternity Testing(NIPPT) Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Perspective (2021-2032)
  2. 3.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Growth Trends by Region
  3. 3.2.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region (2021-2026)
  5. 3.2.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Players
  2. 4.1.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Players (2021-2026)
  3. 4.1.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Key Players Headquarters & Area Served
  7. 4.4 Global Non-invasive Prenatal Paternity Testing(NIPPT) Players, Product Type & Application
  8. 4.5 Global Non-invasive Prenatal Paternity Testing(NIPPT) Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Market CR5 and HHI
  11. 4.6.3 2025 Non-invasive Prenatal Paternity Testing(NIPPT) Tier 1, Tier 2, and Tier 3
5 Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Type
  1. 5.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 5.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Type (2021-2032)
6 Non-invasive Prenatal Paternity Testing(NIPPT) Market Size by Application
  1. 6.1 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  3. 6.3 Global Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BGI Genomics
  2. 7.1.1 BGI Genomics Company Information
  3. 7.1.2 BGI Genomics Business Overview
  4. 7.1.3 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BGI Genomics Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  6. 7.1.5 BGI Genomics Recent Developments
  7. 7.2 Ultrasound Plus
  8. 7.2.1 Ultrasound Plus Company Information
  9. 7.2.2 Ultrasound Plus Business Overview
  10. 7.2.3 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Ultrasound Plus Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  12. 7.2.5 Ultrasound Plus Recent Developments
  13. 7.3 Roche company
  14. 7.3.1 Roche company Company Information
  15. 7.3.2 Roche company Business Overview
  16. 7.3.3 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche company Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  18. 7.3.5 Roche company Recent Developments
  19. 7.4 PrenatalGeneticslab
  20. 7.4.1 PrenatalGeneticslab Company Information
  21. 7.4.2 PrenatalGeneticslab Business Overview
  22. 7.4.3 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  23. 7.4.4 PrenatalGeneticslab Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  24. 7.4.5 PrenatalGeneticslab Recent Developments
  25. 7.5 Natera
  26. 7.5.1 Natera Company Information
  27. 7.5.2 Natera Business Overview
  28. 7.5.3 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Natera Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  30. 7.5.5 Natera Recent Developments
  31. 7.6 LabCorp
  32. 7.6.1 LabCorp Company Information
  33. 7.6.2 LabCorp Business Overview
  34. 7.6.3 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  35. 7.6.4 LabCorp Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  36. 7.6.5 LabCorp Recent Developments
  37. 7.7 International Biosciences
  38. 7.7.1 International Biosciences Company Information
  39. 7.7.2 International Biosciences Business Overview
  40. 7.7.3 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  41. 7.7.4 International Biosciences Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  42. 7.7.5 International Biosciences Recent Developments
  43. 7.8 Illumina
  44. 7.8.1 Illumina Company Information
  45. 7.8.2 Illumina Business Overview
  46. 7.8.3 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Illumina Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  48. 7.8.5 Illumina Recent Developments
  49. 7.9 Express Diagnostic Center (EDC)
  50. 7.9.1 Express Diagnostic Center (EDC) Company Information
  51. 7.9.2 Express Diagnostic Center (EDC) Business Overview
  52. 7.9.3 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Express Diagnostic Center (EDC) Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  54. 7.9.5 Express Diagnostic Center (EDC) Recent Developments
  55. 7.10 EasyDNA
  56. 7.10.1 EasyDNA Company Information
  57. 7.10.2 EasyDNA Business Overview
  58. 7.10.3 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  59. 7.10.4 EasyDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  60. 7.10.5 EasyDNA Recent Developments
  61. 7.11 DDC
  62. 7.11.1 DDC Company Information
  63. 7.11.2 DDC Business Overview
  64. 7.11.3 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  65. 7.11.4 DDC Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  66. 7.11.5 DDC Recent Developments
  67. 7.12 Axis DNA Labs
  68. 7.12.1 Axis DNA Labs Company Information
  69. 7.12.2 Axis DNA Labs Business Overview
  70. 7.12.3 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Axis DNA Labs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  72. 7.12.5 Axis DNA Labs Recent Developments
  73. 7.13 AlphaBiolabs
  74. 7.13.1 AlphaBiolabs Company Information
  75. 7.13.2 AlphaBiolabs Business Overview
  76. 7.13.3 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  77. 7.13.4 AlphaBiolabs Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  78. 7.13.5 AlphaBiolabs Recent Developments
  79. 7.14 AffinityDNA
  80. 7.14.1 AffinityDNA Company Information
  81. 7.14.2 AffinityDNA Business Overview
  82. 7.14.3 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  83. 7.14.4 AffinityDNA Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  84. 7.14.5 AffinityDNA Recent Developments
  85. 7.15 Acecgt Group
  86. 7.15.1 Acecgt Group Company Information
  87. 7.15.2 Acecgt Group Business Overview
  88. 7.15.3 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Acecgt Group Non-invasive Prenatal Paternity Testing(NIPPT) Product Portfolio
  90. 7.15.5 Acecgt Group Recent Developments
8 North America
  1. 8.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2021-2032)
  2. 8.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 8.2.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026)
  4. 8.2.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032)
  5. 8.3 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032)
  6. 8.4 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  7. 8.4.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026)
  8. 8.4.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032)
  9. 8.5 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032)
  10. 8.6 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country
  11. 8.6.1 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026)
  13. 8.6.3 North America Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2021-2032)
  2. 9.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032)
  5. 9.3 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032)
  9. 9.5 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country
  11. 9.6.1 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2021-2032)
  2. 10.2 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 10.2.1 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026)
  4. 10.2.2 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032)
  5. 10.3 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032)
  6. 10.4 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  7. 10.4.1 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026)
  8. 10.4.2 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032)
  9. 10.5 China Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2021-2032)
  2. 11.2 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032)
  5. 11.3 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032)
  9. 11.5 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country
  11. 11.6.1 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue (2021-2032)
  2. 12.2 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country
  11. 12.6.1 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non-invasive Prenatal Paternity Testing(NIPPT) Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst